Capital Research Global Investors
NUVA

Capital Research Global Investors’s NuVasive, Inc. NUVA Stock Holding History

Capital Research Global Investors’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-510,000
Closed -$28.4M – 423
2020
Q2 		$28.4M Hold
510,000
– – 0.01% 358
2020
Q1 		$25.8M Hold
510,000
– – 0.01% 328
2019
Q4 		$39.4M Hold
510,000
– – 0.01% 335
2019
Q3 		$32.3M Hold
510,000
– – 0.01% 350
2019
Q2 		$29.9M Sell
510,000
-90,000
-15% -$5.31M 0.01% 343
2019
Q1 		$34.1M Hold
600,000
– – 0.01% 350
2018
Q4 		$29.7M Hold
600,000
– – 0.01% 345
2018
Q3 		$42.6M Hold
600,000
– – 0.01% 352
2018
Q2 		$31.3M Sell
600,000
-995,500
-62% -$52.1M 0.01% 374
2018
Q1 		$83.3M Sell
1,595,500
-833,913
-34% -$42.3M 0.02% 305
2017
Q4 		$142M Sell
2,429,413
-81,000
-3% -$4.59M 0.04% 257
2017
Q3 		$139M Sell
2,510,413
-349,462
-12% -$23.1M 0.04% 260
2017
Q2 		$220M Sell
2,859,875
-361,120
-11% -$27M 0.07% 217
2017
Q1 		$241M Sell
3,220,995
-1,603,000
-33% -$116M 0.08% 208
2016
Q4 		$325M Sell
4,823,995
-329,905
-6% -$21.3M 0.11% 178
2016
Q3 		$344M Buy
5,153,900
+682,753
+15% +$43.5M 0.11% 172
2016
Q2 		$267M Buy
4,471,147
+260,147
+6% +$14.1M 0.09% 188
2016
Q1 		$205M Buy
4,211,000
+685,600
+19% +$31.1M 0.07% 219
2015
Q4 		$191M Sell
3,525,400
-120,600
-3% -$6.15M 0.07% 226
2015
Q3 		$176M Hold
3,646,000
– – 0.06% 237
2015
Q2 		$173M Buy
3,646,000
+189,000
+5% +$8.84M 0.06% 254
2015
Q1 		$159M Sell
3,457,000
-786,036
-19% -$36.5M 0.05% 260
2014
Q4 		$200M Hold
4,243,036
– – 0.07% 239
2014
Q3 		$148M Buy
4,243,036
+33,200
+0.8% +$1.18M 0.05% 263
2014
Q2 		$150M Buy
4,209,836
+287,915
+7% +$9.86M 0.05% 258
2014
Q1 		$151M Buy
3,921,921
+331,399
+9% +$12.2M 0.05% 245
2013
Q4 		$116M Sell
3,590,522
-200,448
-5% -$6.02M 0.04% 269
2013
Q3 		$92.8M Buy
3,790,970
+437,448
+13% +$10.8M 0.04% 281
2013
Q2 		$83.1M Buy
+3,353,522
New +$73.4M 0.04% 276

Other funds holding NUVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Capital Research Global Investors's NUVA Position: Q3 2020 in Review

Capital Research Global Investors sold out of NuVasive, Inc. (NUVA) in Q3 2020, closing a stake of 510,000 shares — an estimated $28.4M sold.

Capital Research Global Investors first reported a position in NUVA in Q2 2013 and held it in 29 quarters. The position peaked at $344M in Q3 2016. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2020.

  • Capital Research Global Investors reported no remaining NuVasive, Inc. position as of Q3 2020 after selling out during the quarter.
  • Capital Research Global Investors sold 510,000 NuVasive, Inc. shares in Q3 2020, an estimated $28.4M.
  • Capital Research Global Investors first reported a position in NuVasive, Inc. in Q2 2013 and held it in 29 quarters.
  • Capital Research Global Investors's NuVasive, Inc. position peaked at $344M in Q3 2016.
  • 263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2020.

Based on Capital Research Global Investors's 13F filing for Q3 2020, filed 13 Nov 2020.